Wirkstoffe & Arzneimittelsicherheit

Nebenwirkungen · Tepadina

TEPADINA 15 mg powder for concentrate for solution for infusion TEPADINA 100 mg powder for concentrate for solution for infusion · Abschnitt 4.8 · PDF-Seite 10–11

HOS-210401 · Präparat HOS-154509

Ear and Hearing impaired labyrinth Ototoxicity disorders Tinnitus Cardiac Arrhythmia Tachycardia Cardiomyopath disorders Cardiac failure y Myocarditis Vascular Lymphoedema Haemorrhage disorders Hypertension Embolism Respiratory, Idiopathic Pulmonary Hypoxia thoracic and pneumonia oedema mediastinal syndrome Cough disorders Epistaxis Pneumonitis Gastrointestina Nausea Constipation Gastrointestinal l disorders Stomatitis Gastrointestinal ulcer Oesophagitis perforation Vomiting Ileus Diarrhoea Dyspepsia Abdominal pain Enteritis Colitis Hepatobiliary Venoocclusive disorders liver disease Hepatomegaly Jaundice Skin and Rash Erythema Pigmentation Severe toxic skin subcutaneous Pruritus disorder reactions including tissue disorders Alopecia Erythrodermic cases of Stevens- psoriasis Johnson syndrome and toxic epidermal necrolysis Musculoskeleta Back pain l and Myalgia connective Arthralgia tissue disorders Renal and Cystitis Dysuria urinary haemorrhagic Oliguria disorders Renal failure Cystitis Haematuria Reproductive Azoospermia Menopausal system and Amenorrhoea symptoms breast disorders Vaginal Infertility female haemorrhage Infertility male General Pyrexia Multi-organ disorders and Asthenia failure administration Chills Pain site conditions Generalised oedema Injection site inflammation Injection site pain Mucosal inflammation 10  System organ Not known Very common Common Uncommon class

Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.